S. Pavlou

发表

Mice are insensitive to the antitesticular effects of luteinizing hormone-releasing hormone agonists.

W. Vale, J. Rivier, C. Bardin, 1983, Endocrinology.

Suppressive actions of a gonadotropin-releasing hormone antagonist on luteinizing hormone, follicle-stimulating hormone, and prolactin release in estrogen-deficient postmenopausal women.

J D Veldhuis, M. Dufau, W. Vale, 1990, American Journal of Obstetrics and Gynecology.

Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal women.

W. Vale, R. Urban, J. Veldhuis, 1992, The Journal of clinical endocrinology and metabolism.

GnRH Antagonists in Men

S. Pavlou, 1992 .

The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist.

A. Hsueh, S. Pavlou, K. Dahl, 1986, The Journal of clinical endocrinology and metabolism.

Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men.

W. Vale, J. Rivier, C. Debold, 1986, The Journal of clinical endocrinology and metabolism.

Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men.

W. Vale, J. Rivier, S. Pavlou, 1987, The Journal of clinical endocrinology and metabolism.

Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men.

S. Pavlou, W. Kovacs, D. Island, 1987, The Journal of clinical endocrinology and metabolism.

Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studies.

W. Vale, A. Hsueh, S. Yen, 1989, Fertility and sterility.

Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.

J. Lindner, W. Vale, J. Rivier, 1989, The Journal of clinical endocrinology and metabolism.

Recurrent thyroid cancer diagnosis: ROC study of the effect of a high-resolution head and neck 18F-FDG PET/CT scan.

M. Kallergi, G. Kafiri, A. Georgakopoulos, 2014, Academic radiology.

Defective regulation of glycoprotein free alpha-subunit in males with isolated gonadotropin-releasing hormone deficiency--a clinical research center study.

W. Crowley, J. Waldstreicher, F. Pralong, 1995, The Journal of clinical endocrinology and metabolism.

Hormonal regulation of androgen-binding protein in the rat.

S. Pavlou, B. J. Danzo, H. L. Anthony, 1990, Endocrinology.

Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.

J. Lindner, W. Vale, P. Conn, 1991, The Journal of clinical endocrinology and metabolism.

entaaification of Atrial Natriuretic Factor Receptor of Neuroblastoma N4TG1 Cells: Binding Characteristics and Photoaffinity Labeling

K. Misono, R. Takayanagi, T. Inagami, 1987, Journal of neurochemistry.

Regulation of Steroidogenic Responsiveness and Cyclic Nucleotide Levels by Atrial Natriuretic Factor in Isolated Mouse Leydig Cells a

T. Inagami, S. Pavlou, K. Pandey, 1987 .

Atrial natriuretic factor regulates steroidogenic responsiveness and cyclic nucleotide levels in mouse Leydig cells in vitro.

T. Inagami, S. Pavlou, K. Pandey, 1986, Biochemical and biophysical research communications.

ASSESSMENT OF PROLACTIN RELEASE IN PITUITARY DWARFISM WITH THE SULPIRIDE TEST

T. Alexandrides, S. Pavlou, G. Piaditis, 1978, Clinical endocrinology.

Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.

J. Lindner, W. Vale, P. Conn, 1991, Journal of Clinical Endocrinology and Metabolism.

Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function.

D. Orth, C. Debold, T. Kamilaris, 1987, The Journal of clinical endocrinology and metabolism.

The clinical features of the menopause and its relation to the length of pregnancies and lactation.

S. Pavlou, G. Piaditis, M. Batrinos, 1979, Maturitas.

Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells.

M. Jakubowski, S. Pavlou, J. Mortola, 1995, The Journal of clinical endocrinology and metabolism.

Granulosa cells as hormone targets: the role of biologically active follicle-stimulating hormone in reproduction.

B. Fauser, A. Hsueh, T. Bicsak, 1989, Recent progress in hormone research.

Sperm motion parameters after suppression of spermatogenesis with a gonadotropin-releasing hormone antagonist plus testosterone supplementation.

S. Pavlou, H. Kamijo, M. C. Bastias, 1993 .

Gonadotropin-releasing hormone-dependent chorionic gonadotropin secretion in a menopausal woman.

G. Braunstein, C. Coutifaris, J. Strauss, 1994, The Journal of clinical endocrinology and metabolism.

Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men.

J. Lindner, W. Vale, J. Rivier, 1990, The Journal of clinical endocrinology and metabolism.

Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.

J D Veldhuis, J. Lindner, W. Vale, 1990, The Journal of clinical endocrinology and metabolism.

Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist.

R. Sergott, T. Gennarelli, W. Vale, 1990, The Journal of clinical endocrinology and metabolism.

Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.

J. Lindner, W. Vale, J. Rivier, 1988, The Journal of clinical endocrinology and metabolism.

Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone.

W. Vale, J. Rivier, S. Pavlou, 1986, Journal of andrology.

Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone.

A. Hsueh, P. Snyder, S. Pavlou, 1990, The Journal of clinical endocrinology and metabolism.

Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation.

S. Asa, C. Coutifaris, S. Kapoor, 1995, The Journal of clinical endocrinology and metabolism.

Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.

S. Pavlou, J. Mortola, M. Alper, 1995, American journal of obstetrics and gynecology.

New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist.

J. Udupa, R. Grossman, W. Vale, 1993, The Journal of clinical endocrinology and metabolism.

THE SULPIRIDE TEST IN PANHYPOPITUITARISM

T. Alexandrides, S. Pavlou, S. Pitoulis, 1978 .

LHRH Antagonists in Normal Men

S. Pavlou, W. Kovacs, G. Wakefield, 1987 .

Effects on behavior of modulation of gonadal function in men with gonadotropin-releasing hormone antagonists.

S. Purdon, S. Pavlou, P. Loosen, 1994, The American journal of psychiatry.

Identification and characterization of three distinct atrial natriuretic factor receptors. Evidence for tissue-specific heterogeneity of receptor subtypes in vascular smooth muscle, kidney tubular epithelium, and Leydig tumor cells by ligand binding, photoaffinity labeling, and tryptic proteolysis.

T. Inagami, S. Pavlou, K. Pandey, 1988, The Journal of biological chemistry.

Clinical Pharmacology of LHRH Antagonists

W. Vale, J. Rivier, T. Kamilaris, 1990 .

Pituitary hormonal profile in menopause.

S. Pavlou, G. Piaditis, M. Batrinos, 1979, Maturitas.